N/A Completed N=51 Randomized Treatment

Nutrigenomics: Personalizing Weight Loss for Obese Veterans

Obesity

Source: ClinicalTrials.gov NCT01859403 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2021

Primary outcomePrimary: Number of Participants With Weight Loss of 5% or More at 8 Weeks — 7; 7 Participants

Summary

This study aims to determine if providing genomic information to veterans can help them lose weight compared to usual care.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Weight Loss of 5% or More at 8 Weeks	7; 7	—
SECONDARY Number of Participants With Weight Loss of 5% or More at 24 Weeks	5; 7	—

Eligibility Criteria

Inclusion Criteria

Veterans able to receive care at the VASDHS and planning to start the MOVE! program.
Veterans able to understand and consent to the study.
BMI equal to or greater than 30 kg/m2.

Exclusion Criteria

Veterans unable to receive care at the VASDHS.
Veterans unable to understand the consent process at the discretion of the PI.
Active substance abuse or substance dependence disorder
Cognitive disorder, psychiatric hospitalization in past 6-months, or presence of suicidal ideation identified on self-report instruments
Bradycardia, rapid heart rate or other arrhythmia or active ischemia by EKG.
Uncontrolled thyroid disease as measured by a TSH above or below the normal range.
Body mass index 190 mg/dl.
Veterans with fasting triglyceride levels > 1000 mg/dl.
Excessive caffeine use (>6 caffeinated beverages/days).
Prior gastrointestinal surgery with the exception of distal appendectomy.
Acute infections or current use of antibiotic therapy.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01859403). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.